To investigate the safety and effectiveness about administration of both donepezil hydrochloride and menatine hydrochloride in patients with Alzheimer's Disease in clinical practice.
Inclusion criteria:
Patients diagnosed with Alzheimer's Disease who are to be administered both donepezil hydrochloride and memantine hydrochloride in clinical practice.
Exclusion criteria:
Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.
Multiple Locations, Japan